Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
This clinical trial studies adherence to survivorship care guidelines in health care providers for non-small cell lung cancer or colorectal cancer survivor care. The completion of an educational intervention by health care providers may increase compliance and adherence to National Comprehensive Cancer Network guidelines for survivorship care.
Checked against the public recordLast updated Apr 6, 2017 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Fox Chase Cancer Center
- Interventions being studied
- Other: educational intervention; Other: medical chart review
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * HEALTH CARE PROVIDER INCLUSION CRITERIA: * Any health care provider (physician, advanced practice clinician) at a study site (Fox Chase Cancer Center \[FCCC\] and Fox Chase Cancer Center Partners \[FCCCP\]) who provides care for NSCLC and/or CRC survivors * CHART AUDIT INCLUSION CRITERIA (BASELINE): * Cancer Registry cases include stage I-III colon cancer (adenocarcinoma histology), stage I-III rectal cancer (adenocarcinoma histology), stage I-III non-small cell lung cancer (squamous or adenocarcinoma histology) * Patients must have completed all therapy for curative intent at least six months prior to chart audit * Undergoing routine oncology care and surveillance at the chosen site (defined as receiving follow-up care with FCCC or FCCCP site health care providers and have an active medical chart) * No evidence of metastatic disease * Patients must have been seen for a visit for cancer surveillance between 2009 and 2013 * Health care providers at the participating site must be willing and able to participate in the educational initiative * CHART AUDIT INCLUSION CRITERIA (POST-INTERVENTION) * Charts eligible for audit after completion of the educational initiative will be for those CRC and NSCLC survivors presenting for follow-up after the initiative has been completed by site health care providers Exclusion Criteria: * CHART AUDIT EXCLUSION CRITERIA: * Cancer Registry cases for diseases other than colon or rectal adenocarcinoma and non-small cell lung cancer (squamous or adenocarcinoma histology) * Patients currently receiving active therapy for any cancer, including CRC or NSCLC * Patients who do not undergo routine oncologic care at the chosen Partners site or Fox Chase Cancer Center * Stage IV cancer or evidence of metastatic disease at any time point * Patients who have not undergone a visit for cancer surveillance since 2009 * Fox Chase Cancer Partners sites who do not agree to chart audit procedures or providers are unable or unwilling to participate in the educational initiative
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Fox Chase Cancer CenterPhiladelphia, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 6, 2017. Always confirm current availability with the study team.